Unknown

Dataset Information

0

Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy.


ABSTRACT: Viral infections lead to alarmin release and elicit potent cytotoxic effector T lymphocyte (CTLeff) responses. Conversely, the induction of protective tumour-specific CTLeff and their recruitment into the tumour remain challenging tasks. Here we show that lymphocytic choriomeningitis virus (LCMV) can be engineered to serve as a replication competent, stably-attenuated immunotherapy vector (artLCMV). artLCMV delivers tumour-associated antigens to dendritic cells for efficient CTL priming. Unlike replication-deficient vectors, artLCMV targets also lymphoid tissue stroma cells expressing the alarmin interleukin-33. By triggering interleukin-33 signals, artLCMV elicits CTLeff responses of higher magnitude and functionality than those induced by replication-deficient vectors. Superior anti-tumour efficacy of artLCMV immunotherapy depends on interleukin-33 signalling, and a massive CTLeff influx triggers an inflammatory conversion of the tumour microenvironment. Our observations suggest that replicating viral delivery systems can release alarmins for improved anti-tumour efficacy. These mechanistic insights may outweigh safety concerns around replicating viral vectors in cancer immunotherapy.

SUBMITTER: Kallert SM 

PROVIDER: S-EPMC5458557 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


Viral infections lead to alarmin release and elicit potent cytotoxic effector T lymphocyte (CTL<sup>eff</sup>) responses. Conversely, the induction of protective tumour-specific CTL<sup>eff</sup> and their recruitment into the tumour remain challenging tasks. Here we show that lymphocytic choriomeningitis virus (LCMV) can be engineered to serve as a replication competent, stably-attenuated immunotherapy vector (artLCMV). artLCMV delivers tumour-associated antigens to dendritic cells for efficien  ...[more]

Similar Datasets

2017-03-08 | GSE84039 | GEO
| S-EPMC6533917 | biostudies-literature
| S-EPMC3823082 | biostudies-other
| S-EPMC9818975 | biostudies-literature
| S-EPMC7927015 | biostudies-literature
| S-EPMC4635936 | biostudies-literature
| S-EPMC6838956 | biostudies-literature
| S-EPMC6309998 | biostudies-literature
| S-EPMC1635018 | biostudies-literature
| S-EPMC7140650 | biostudies-literature